Hemogenyx Pharmaceuticals Plc (HEMO.L)

GBp 320.0

(-8.57%)

Net Income Summary of Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc's latest annual net income in 2023 was -6.69 Million GBP , down -53.87% from previous year.
Hemogenyx Pharmaceuticals Plc's latest quarterly net income in 2024 Q2 was -1406.42 GBP , down 0.0% from previous quarter.
Hemogenyx Pharmaceuticals Plc reported an annual net income of -4.34 Million GBP in 2022, up 42.2% from previous year.
Hemogenyx Pharmaceuticals Plc reported an annual net income of -7.52 Million GBP in 2021, down -255.61% from previous year.
Hemogenyx Pharmaceuticals Plc reported a quarterly net income of -1406.42 GBP for 2024 Q1, down -18.71% from previous quarter.
Hemogenyx Pharmaceuticals Plc reported a quarterly net income of -1184.79 GBP for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Hemogenyx Pharmaceuticals Plc (2023 - 2014)

Historical Annual Net Income of Hemogenyx Pharmaceuticals Plc (2023 - 2014)

Year	Net Income	Net Income Growth
2023	-6.69 Million GBP	-53.87%
2022	-4.34 Million GBP	42.2%
2021	-7.52 Million GBP	-255.61%
2020	-2.11 Million GBP	-45.58%
2019	-1.45 Million GBP	1.65%
2018	-1.47 Million GBP	37.44%
2017	-2.36 Million GBP	-354.24%
2016	-519.89 Thousand GBP	-187.43%
2015	-180.87 Thousand GBP	-2784.78%
2014	-6270.00 GBP	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-1406.42 GBP	0.0%
2024 Q1	-1406.42 GBP	-18.71%
2023 Q4	-1184.79 GBP	0.0%
2023 FY	-6.69 Million GBP	-53.87%
2023 Q2	-4.32 Million GBP	-199899.95%
2023 Q3	-1184.79 GBP	99.97%
2023 Q1	-2160.55 GBP	99.92%
2022 Q2	-1.12 Million GBP	-199899.82%
2022 Q1	-563.84 GBP	99.96%
2022 Q4	-2.85 Million GBP	-199900.07%
2022 FY	-4.34 Million GBP	42.2%
2022 Q3	-1425.82 GBP	99.87%
2021 Q3	-734.04 GBP	99.98%
2021 Q2	-3.63 Million GBP	-199900.0%
2021 Q1	-1815.57 GBP	99.85%
2021 Q4	-1.46 Million GBP	-199900.0%
2021 FY	-7.52 Million GBP	-255.61%
2020 Q1	-416.16 GBP	99.94%
2020 FY	-2.11 Million GBP	-45.58%
2020 Q3	-624.95 GBP	99.92%
2020 Q4	-1.24 Million GBP	-199900.0%
2020 Q2	-832.31 Thousand GBP	-199900.0%
2019 Q1	-353.34 GBP	21.21%
2019 Q4	-743.95 Thousand GBP	-199899.73%
2019 FY	-1.45 Million GBP	1.65%
2019 Q2	-706.67 Thousand GBP	-199900.0%
2019 Q3	-371.98 GBP	99.95%
2018 Q3	-448.45 GBP	-38.53%
2018 Q2	-323.71 GBP	0.0%
2018 Q1	-323.71 GBP	70.89%
2018 FY	-1.47 Million GBP	37.44%
2018 Q4	-448.45 GBP	0.0%
2017 Q4	-1112.22 GBP	0.0%
2017 Q2	-68.59 GBP	0.0%
2017 Q3	-1112.22 GBP	-1521.66%
2017 Q1	-68.59 GBP	0.0%
2017 FY	-2.36 Million GBP	-354.24%
2016 Q4	- GBP	0.0%
2016 Q2	- GBP	0.0%
2016 FY	-519.89 Thousand GBP	-187.43%
2015 FY	-180.87 Thousand GBP	-2784.78%
2014 FY	-6270.00 GBP	0.0%

Peer Net Income Comparison of Hemogenyx Pharmaceuticals Plc

Name	Net Income	Net Income Difference